Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Laboratory Corp. of America Holdings    LH

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Laboratory Corp. of America Holdings : LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021 to Accrue Contingent Interest

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/13/2012 | 10:05pm CET

Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) announced today that for the period of March 12, 2012 to September 11, 2012, its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) will, subject to the terms of the Zero Coupon Notes, accrue contingent cash interest at a rate of no less than 0.125% of the average market price of a Zero Coupon Note for the five trading days ended March 7, 2012, in addition to the continued accrual of the original issue discount. Contingent cash interest, which the Company has determined to be approximately $1.50 per Note, will be payable to holders of the Zero Coupon Notes as of the record date, which is August 26, 2012. The payment of contingent cash interest is expected to be made on September 11, 2012.

About LabCorp®

Laboratory Corporation of America® Holdings, an S&P 500 company, is a pioneer in commercializing new diagnostic technologies and the first in its industry to embrace genomic testing. With annual revenues of $5.5 billion in 2011, over 31,000 employees worldwide, and more than 220,000 clients, LabCorp offers more than 4,000 tests ranging from routine blood analyses to reproductive genetics to companion diagnostics. LabCorp furthers its scientific expertise and innovative clinical testing technology through its specialized labs and the LabCorp Specialty Testing Group: The Center for Molecular Biology and Pathology, National Genetics Institute, ViroMed Laboratories, Inc., The Center for Esoteric Testing, Litholink Corporation, Integrated Genetics, Integrated Oncology, DIANON Systems, Inc., Monogram Biosciences, Inc., Colorado Coagulation, and Endocrine Sciences. LabCorp conducts clinical trials testing through its Esoterix Clinical Trials Services. LabCorp clients include physicians, government agencies, managed care organizations, hospitals, clinical labs, and pharmaceutical companies. To learn more about our organization, visit our Web site at: www.labcorp.com.

This press release contains forward-looking statements. Each of the forward-looking statements is subject to change based on various important factors, including without limitation, competitive actions in the marketplace and adverse actions of governmental and other third-party payors. Actual results could differ materially from those suggested by these forward-looking statements. Further information on potential factors that could affect LabCorp's financial results is included in the Company's Form 10-K for the year ended December 31, 2011, and subsequent SEC filings.

LabCorp
Stephen Anderson, 336-436-5274
www.labcorp.com


© Business Wire 2012
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on LABORATORY CORP. OF AMERIC
01/11 LABORATORY OF AMERICA : Sera Prognostics Enters into Agreement with LabCorp to b..
01/11 AMERICA HOLDINGS (NASDAQ : LH) Files An 8-K Regulation FD Disclosure
01/10 LABORATORY CORP OF AMERICA HOLDINGS : Regulation FD Disclosure (form 8-K)
01/10 LABORATORY OF AMERICA : LabCorp to Acquire Assets of Mount Sinai Health System C..
01/10 AMERICA HOLDINGS (NASDAQ : LH) Files An 8-K Material Modification to Rights of S..
01/10 AMERICA HOLDINGS (NYSE : LH) Files An 8-K Material Modification to Rights of Sec..
01/09 LABORATORY CORP OF AMERICA HOLDINGS : Material Modification to Rights of Securit..
01/05 LABORATORY CORP OF AMERICA HOLDINGS : Regulation FD Disclosure (form 8-K)
01/05 LABORATORY OF AMERICA : LabCorp is Scheduled to Present at the 35th Annual J.P. ..
01/03 AMERICA HOLDINGS (NASDAQ : LH) Files An 8-K Regulation FD Disclosure
More news
Sector news : Healthcare Facilities & Services - NEC
01/13DJDAVITA : Judge Blocks Rule That Could Limit Premium Assistance for Dialysis Pati..
01/07DJFRESENIUS MEDICAL CARE : Impact Of Potential Regulation Change
2016 FTSE nudges higher though banks, Ashtead slide
2016DJQuest Diagnostics Reports Data Breach
2016DJUNIVERSAL HEALTH SERVICES : Denies Report of Filling Beds Solely for Financial G..
More sector news : Healthcare Facilities & Services - NEC
News from SeekingAlpha
07:50a Premarket analyst action - healthcare
01/11 Laboratory Corporation of America Holdings (LH) presents at 35th Annual J.P. ..
01/10 LabCorp buys NY-based Mount Sinai's outreach labs
2016 Tracking Wallace Weitz's Weitz Investment Management Portfolio - Q3 2016 Upda..
2016 Tracking Larry Robbins' Glenview Capital Management Portfolio - Q3 2016 Updat..
Advertisement
Financials ($)
Sales 2016 9 403 M
EBIT 2016 1 486 M
Net income 2016 730 M
Debt 2016 5 326 M
Yield 2016 -
P/E ratio 2016 18,80
P/E ratio 2017 15,69
EV / Sales 2016 2,03x
EV / Sales 2017 1,86x
Capitalization 13 801 M
More Financials
Chart LABORATORY CORP. OF AMERIC
Duration : Period :
Laboratory Corp. of Americ Technical Analysis Chart | LH | US50540R4092 | 4-Traders
Full-screen chart
Technical analysis trends LABORATORY CORP. ...
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 146 $
Spread / Average Target 9,2%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
David P. King Chairman, President & Chief Executive Officer
Glenn A. Eisenberg Chief Financial Officer, Treasurer & Executive VP
Mark Elliott Brecher Chief Medical Officer & Senior Vice President
Lance V. Berberian Chief Information Officer & Senior Vice President
Marcia T. Eisenberg Chief Scientific Officer & Senior Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
LABORATORY CORP. OF AM..4.37%13 801
HCA HOLDINGS INC9.34%30 323
FRESENIUS MEDICAL CARE..-5.48%25 348
QUEST DIAGNOSTICS INC0.39%12 791
DAVITA INC-0.55%12 604
UNIVERSAL HEALTH SERVI..7.45%11 085
More Results